Medication info

Catahilon Injection (Sodium Hyaluronate)

Prescription medicationInjectionsInjection
Ingredient · strength
Sodium Hyaluronate›15mg / 1mL
Manufacturer / importer
Aju Pharmaceutical Co., Ltd.
Appearance
A colorless, transparent, viscous solution contained in a colorless, transparent glass or plastic tube (part of a pre-filled syringe system) sealed with rubber stoppers at both ends.
Packaging
0.85mL/tube*1
Approval status
Active

MFDS item code 201905546 · Notified 2019.08.06 · Insurance code 654005481

Summary

Main use
Adjunctive treatment for ophthalmic surgery (cataract surgery, corneal transplantation, etc.)
Who receives it
Adults
Adult administration
1. Cataract surgery and intraocular lens implantation Slowly inject the required amount of this medicine into the anterior chamber of the eye through a needle or cannula before or after lens removal. Since the optimal corneal endothelial protection as an adjunct may be achieved only when injected before cataract extraction and intraocular lens insertion, inject it before intracapsular and extracapsular cataract surgery. This medicine may be used to coat surgical instruments and the intraocular lens to be implanted. 2. Corneal transplantation After removing the corneal graft, fill the anterior chamber with this medicine until it is level with the corneal surface. Place the donor graft on top of this medicine and suture it in place. 3. Glaucoma filtration surgery Inject this medicine through a corneal paracentesis to replenish and maintain the anterior chamber volume during trabeculectomy.

Ingredients

Manufacturer
Aju Pharmaceutical Co., Ltd.

Efficacy & effects

Adjunctive treatment for ophthalmic surgery (cataract surgery, corneal transplantation, etc.)

View approved original text

This medication is used to assist in various ophthalmic surgeries such as lens implantation during cataract surgery, corneal graft surgery, and glaucoma surgery.

How it is given

Adult administration

1. Cataract surgery and intraocular lens implantation Slowly inject the required amount of this medicine into the anterior chamber of the eye through a needle or cannula before or after lens removal. Since the optimal corneal endothelial protection as an adjunct may be achieved only when injected before cataract extraction and intraocular lens insertion, inject it before intracapsular and extracapsular cataract surgery. This medicine may be used to coat surgical instruments and the intraocular lens to be implanted. 2. Corneal transplantation After removing the corneal graft, fill the anterior chamber with this medicine until it is level with the corneal surface. Place the donor graft on top of this medicine and suture it in place. 3. Glaucoma filtration surgery Inject this medicine through a corneal paracentesis to replenish and maintain the anterior chamber volume during trabeculectomy.

Precautions

This drug contains sodium hyaluronate and is primarily used after eye surgery. It should not be administered to patients who have a hypersensitivity to the ingredients or protein-based drugs included in this medication. During use, the eye pressure may temporarily increase, and side effects such as inflammation, corneal edema, opacity, bleeding, pain, itching, visual impairment, etc., may rarely occur. Additionally, care should be taken as there is a possibility of opacity developing on the surface of the intraocular lens. As this medication contains phosphate, there have been very rare reports of corneal calcification occurring in patients with severe corneal damage. The eye pressure must be carefully checked immediately after surgery, and appropriate measures should be taken if the pressure increases. If possible, it is advisable to wash or aspirate this medication after surgery to remove it. Before conducting ultrasonic emulsification aspiration, a procedure to create a space with a perfusate between the lens and this medication must be performed. Avoid using solutions containing quaternary ammonium compounds such as benzalkonium chloride to clean surgical instruments. This medication should not be used in conjunction with hyaluronidase, as there is a risk of interaction. This medication is for ophthalmic use only and must never be injected intravenously. Before use, the refrigerated medication should be left at room temperature for about 30 minutes to reach an appropriate temperature. Care must be taken as contact with benzalkonium chloride and chlorhexidine may cause precipitation. After opening, it should be used only once, and any remaining medication should be discarded along with the container. When mixing the medication with air for use, care must be taken to prevent air from entering under the iris. When injecting, do so slowly and cautiously, and ensure that it is not over-injected, as this can increase eye pressure. This medication should be stored out of the reach of children, protected from direct sunlight, and kept in a sealed container in a cool, dry place. Additionally, to preserve quality and prevent misuse, it should not be transferred to another container.

Side effects

Increased intraocular pressure, inflammatory response, corneal edema, corneal opacity, anterior chamber hemorrhage, iris neovascularization, iris posterior ulcers, conjunctival adhesion deficiency, mydriasis, lens opacity, pain, pruritus, blurred vision, corneal dystrophy, opacification of intraocular lens surface, corneal calcification

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air and light. Additionally, it is advisable to store it in a dark place away from direct sunlight. The storage temperature should be maintained between 2 and 8 degrees Celsius, and care should be taken to prevent freezing.

Appearance and packaging

Appearance

A colorless, transparent, viscous solution contained in a colorless, transparent glass or plastic tube (part of a pre-filled syringe system) sealed with rubber stoppers at both ends.

Package unit

0.85mL/tube*1

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.